3rd Annual Immuno-Oncology Summit Europe
-第3届欧洲癌症免疫高峰会-
日期:2018年3月19-23日
地点:英国伦敦,Hilton Canary Wharf

会议日程

Adoptive T-Cell Therapy 
Combination Immunotherapy 
Immunomodulatory Antibodies 

关于活动

第3届Immuno-Oncology Summit Europe由Cambridge Healthtech Institute (CHI)主办,将在位于英国伦敦中心的Canary Wharf 举行,针对尖端研究成果进行为期一周活络的讨论。高峰会由3组会议日程接连组成,能够聆听领导快速发展癌症生物治疗药物领域的研究团队发表。第一组会议日程主题为T细胞输入疗法,聚焦利用CAR-T、TCR、TIL的次世代治疗药物及促进先天免疫系统参与的方法等议题。同时安排了会议讨论T细胞基因工程技术、临床前模型、生产方法,亦聚焦特异性及off-target毒性、安全性。紧接著登场的会议日程以并用免疫疗法为主题,探讨设计免疫疗法合理并用法的策略及方法,介绍免疫调节组合、检查点抑制剂及其他模态的并用、生物标记和以机制为基础的并用癌症免疫疗法选择相关案例研讨。最后一个日程则以具免疫调节机能的抗体为主题,将发表检查点抑制剂、激动剂受体作用、NK细胞及巨噬细胞活性化、双特异性抗体、Fc工程技术等领域之研究成果,并讨论对检查点抑制剂无反应的肿瘤课题。

上届与会者回响

"The breadth and depth of the presentations was outstanding and resulted in many interesting conversations and contacts. This is what makes or breaks an event at the end of the day. The event, logistics and location were faultless too."
Senior Scientific Investigator, Systems Modeling and Translational Biology, GlaxoSmithKline

"Incredible line up of the brightest minds in immuno-oncology." 
Analyst, Aquilo Capital Management

"Thank you for the organizing such a great meeting. I enjoyed very much the wide coverage of talks from big and small pharma in the field of immuno-oncology." 
Senior Scientist, Cancer Immunotherapy Discovery, Roche Innovation Center Zurich

继续阅读